Материал: ABC-of-Rheumatology-ABC-Series-

Внимание! Если размещение файла нарушает Ваши авторские права, то обязательно сообщите нам

Sports and Exercise Medicine

147

 

 

 

 

acteristics (e.g. age) and preferences. Patients in moderateto severe-cardiac-risk groups should be assessed with an exercise test before commencing a programme. Supervision of patients may be necessary. Compliance is enhanced by education and counselling, careful prescription in choice of activities, written information about the programme, goal setting and frequent follow up, which may be done by telephone.

Summary

The evidence supporting the benefits of exercise/an active lifestyle both in preserving and restoring health is irrefutable. An active lifestyle will inevitably result in occasional musculoskeletal “injury”, and while sports and exercise medicine has now been recognized

as a medical specialty and thus should have increased NHS provision, the rheumatologist will still have a valuable role in contributing to the wider impact of activity-related musculoskeletal injury. It is therefore important that rheumatologists are confident in the assessment and rehabilitation of the exercising individual.

Further reading

Brukner P, Kahn K. Clinical Sports Medicine, 3rd edn. McGraw-Hill, Australia, 2007.

MacAuley D. Oxford Handbook of Sport and Exercise Medicine, 1st edn. Oxford University Press, Oxford, 2007.

MacAuley D, Best T. Evidenced-based Sports Medicine, 1st edn. BMJ Publishing Group, London, 2002.

CHAPTER 23

Vasculitis and Related Rashes

Richard A Watts1,2 and David G I Scott3

1University of East Anglia, Norwich, UK

2Ipswich Hospital NHS Trust, Ipswich, UK

3Norfolk and Norwich University Hospital NHS Trust, Norwich, UK

OVERVIEW

 

initially present with a non-specific illness and later with loss of

 

pulse, claudication (especially of the upper limbs) and stroke.

Systemic vasculitis should be considered in the differential

 

 

 

 

 

diagnosis of all patients presenting with multi-system illness.

 

Medium-vessel vasculitis

Cytoplasmic anti-neutrophil cytoplasmic antibodies (cANCA)

 

 

with proteinase 3 antibodies are associated with Wegener’s

 

Classical polyarteritis nodosa

 

granulomatosis, and perinuclear ANCA (pANCA) with

 

 

A multi-system vasculitis characterized by formation of microan-

 

myeloperoxidase antibodies are associated with microscopic

 

 

eurysms in medium-sized arteries. Patients present with a consti-

 

polyangiitis.

 

Urinalysis is a key investigation, as renal involvement is a major

 

 

 

 

determinant of outcome.

 

 

 

Treatment depends on the type of vasculitis, following guidelines

 

Box 23.1 Symptoms suggestive of vasculitis

 

 

from the British Society for Rheumatology and the European

 

 

 

 

 

 

League against Rheumatism.

 

Systemic

Cyclophosphamide therapy should be used only for induction of

 

 

Malaise

 

remission; maintenance therapy should be with azathioprine or

 

Fever

 

methotrexate in combination with glucocorticoids.

 

Weight loss

 

 

 

Myalgia

 

 

 

 

 

Arthralgia

 

 

 

Skin

The vasculitides are a heterogeneous group of uncommon diseases

 

Purpura (palpable)

 

Ulceration

characterized by inflammatory cell infiltration and necrosis of

 

Infarction

blood-vessel walls. Systemic necrotizing vasculitis can be rapidly

 

Gastrointestinal

life-threatening, so early accurate diagnosis and treatment is vital.

 

 

Mouth ulcers

Vasculitis may be primary (Wegener’s granulomatosis, Churg–

 

 

Abdominal pain

Strauss syndrome, microscopic polyangiitis and polyarteritis

 

Diarrhoea

nodosa) or secondary to established connective tissue disease (such

 

Respiratory

as rheumatoid arthritis), infection or malignancy. The severity of

 

 

Cough

vasculitis is related to the size and site of the vessels affected.

 

 

Wheeze

Classification is based on vessel size and determines the treatment

 

 

Haemoptysis

approach (Table 23.1; Box 23.1).

 

Dyspnoea

Large-vessel vasculitis

 

Ear, nose and throat

 

Epistaxis

Large-vessel vasculitis includes giant cell arteritis and Takayasu’s

 

Crusting

 

Sinusitis

arteritis. Giant cell arteritis is described elsewhere (Chapter 17).

 

 

Deafness

Takayasu’s arteritis is uncommon and affects young adults, who

 

Cardiac

 

 

 

 

 

 

Chest pain

 

 

 

Neurological

ABC of Rheumatology, 4th edn. Edited by Ade Adebajo.

 

Sensory or motor impairment

©2010 Blackwell Publishing Ltd. 9781405170680.

 

 

 

 

 

 

148

 

 

 

Vasculitis and Related Rashes

149

 

 

 

 

Table 23.1 Classification of vasculitis

 

 

 

 

 

 

 

 

 

 

 

Vessels

Primary

Secondary

 

 

predominantly

 

 

 

 

affected

 

 

 

 

 

 

 

 

 

Large arteries

Giant cell arteritis

Aortitis associated with

 

 

 

Takayasu’s arteritis

rheumatoid arthritis

 

 

 

 

Infection (syphilis)

 

 

Medium arteries

Classic polyarteritis

Infection (hepatitis B)

 

 

 

nodosa

 

 

 

 

Kawasaki disease

 

 

 

Medium arteries and

Wegener’s

Rheumatoid arthritis,

 

 

small vessels

granulomatosis

systemic lupus

 

 

 

Churg–Strauss syndrome

erythematosus

 

 

 

Microscopic polyangiitis

Sjögren’s syndrome

 

 

 

 

Drugs

 

 

 

 

Infection (HIV)

 

 

Small vessels

Henoch–Schönlein

Drugs

Figure 23.1 Coeliac axis arteriogram showing typical aneurysm in

 

(leucocytoclastic)

purpura

Infection (hepatitis C)

 

 

Cryoglobulinaemia

 

polyarteritis nodosa

 

Leucocytoclastic vasculitis

tutional illness, which is often associated with rash, mononeuritis multiplex, vascular hypertension and organ infarction. Polyarteritis nodosa may be confined to the skin. Angiography shows typical microaneurysms (Figure 23.1). Polyarteritis nodosa is associated with hepatitis B infection.

Kawasaki disease (mucocutaneous lymph node syndrome)

An acute vasculitis that primarily affects infants and young children. It presents with fever, rash, lymphadenopathy and palmoplantar erythema. Coronary arteries become affected in up to one-quarter of untreated patients; this can lead to myocardial ischaemia and infarction.

Mediumand small-vessel vasculitis

This group includes the major necrotizing vasculitides: microscopic polyangiitis, Wegener’s granulomatosis and Churg–Strauss syndrome, with involvement of both medium and small arteries. These may occur at any age, with the peak incidence at 60–70 years and are slightly more common in men. The annual incidence is about 20 cases per million people. The symptoms depend on the size and site of the vessel affected and on the individual diagnosis. They are associated with the presence of anti-neutrophil cytoplasmic antibodies (ANCA).

Wegener’s granulomatosis

This is characterized by a granulomatous vasculitis of the upper and lower respiratory tracts and glomerulonephritis, but almost any organ system can be affected (Figure 23.2). The lungs are affected in 45% of patients at diagnosis. Symptoms in the ear, nose and throat (such as epistaxis, crusting and deafness) are particularly associated with this condition, and they should be sought in all patients with suspected vasculitis. Patients with limited Wegener’s

granulomatosis—disease without renal involvement—may have a better prognosis. Biopsy of affected organs shows a necrotizing arteritis, often with formation of granulomas (Figure 23.3).

Microscopic polyangiitis

This is characterized by a vasculitis that commonly affects the kidneys. Lung involvement usually presents with haemoptysis caused by pulmonary capillaritis and haemorrhage (pulmonaryrenal syndrome).

Biopsy of the kidney shows a focal segmental necrotizing glomerulonephritis with few immune deposits (sometimes called pauci-immune vasculitis).

Churg–Strauss syndrome

This syndrome is characterized by atopy (especially late-onset asthma), pulmonary involvement (75% of patients have radiographic evidence of infiltration) and eosinophilia in the tissues and peripheral blood (>1 × 109/l). Such features can develop several years before the onset of systemic vasculitis. Cardiac involvement is a particular feature of Churg–Strauss syndrome and determines prognosis. Neuropathy is common.

Small-vessel vasculitis

Small-vessel vasculitis (leucocytoclastic or hypersensitivity) is usually confined to the skin, but it may be part of a systemic illness. The rash is purpuric, sometimes palpable, and occurs in dependent areas. The lesions may become bullous and ulcerate. Nailfold infarcts occur. Biopsy shows a cellular infiltrate of small vessels often with leucocytoclasis (fragmented polymorphonuclear cells and nuclear dust). Small-vessel vasculitis has a number of causes, of which drugs and infection are the most common.

150 ABC of Rheumatology

(a)

(b)

Figure 23.2 Wegener’s granulomatosis; (a) typical saddle nose deformity (reproduced with patient’s permission); (b) vasculitic rash

Figure 23.3 Computed tomography scan of thorax, showing a granuloma in Wegener’s granulomatosis

Henoch–Schönlein purpura

This is a form of small-vessel vasculitis that occurs mainly in children and young adults. Patients present with rash, arthritis, abdominal pain and, sometimes, renal involvement (Figure 23.4). Deposits of immunoglobulin A can be detected histologically in the skin and renal mesangium.

Cryoglobulinaemia

Cryoglobulins are plasma proteins that precipitate in the cold. The condition presents with rash (including purpura digital ischaemia and ulcers) (Figure 23.5), arthralgia and neuropathy. A strong link exists between infection with hepatitis C virus and essential mixed cryoglobulinaemia: 80–90% of such patients are positive for antihepatitis C virus antibodies.

Behçet’s syndrome

Behçet’s syndrome is a systemic vasculitis of unknown aetiology, characterized by oro-genital ulceration. It is most common in Turkey and Japan. Ocular involvement occurs early in the disease course and affects 50% of patients. The pathergy phenomenon is characteristic and is a non-specific hyperreactivity in response to minor trauma.

Investigation

Investigation aims to establish and confirm the diagnosis, the extent and severity of organ involvement, and disease activity (Box 23.2).

Urine analysis

This is the most important investigation, because the severity of renal involvement is one of the key determinants of prognosis. Detection of proteinuria or haematuria in a patient with systemic illness needs immediate further investigation, and the patient is a medical emergency.

Vasculitis and Related Rashes

151

 

 

 

 

(a)

(b)

Figure 23.4 Small-vessel vasculitis in Henoch–Schönlein purpura; (a) affecting the skin; (b) affecting the gut

 

 

Box 23.2 Investigation of vasculitis

 

Assessing inflammation

 

Blood count and differential (total white cell count, eosinophils)

 

Acute-phase response (erythrocyte sedimentation rate, C-reactive

 

 

protein)

 

Liver function

 

Assessment of organ involvement

 

Urine analysis (proteinuria, haematuria, protein excretion)

 

Renal function (creatinine clearance, 24-hour protein excretion,

 

 

urine protein/creatinine ratio biopsy)

 

Chest radiograph

 

Liver function

 

Nervous system (nerve-conduction studies, biopsy)

 

Cardiac function (electrocardiography, echocardiography)

 

Gut (angiography)

Figure 23.5 Vasculitic rash in cryoglobulinaemia

Immunological tests

Antineutrophil cytoplasmic antibodies (including proteinase 3

 

 

 

and myeloperoxidase antibodies)

 

Other autoantibodies (rheumatoid factor, antinuclear antibodies,

Blood tests

 

anticardiolipin antibodies)

Complement

Leucocytosis suggests a primary vasculitis or infection. Leucopaenia

Cryoglobulins

is associated with vasculitis secondary to a connective tissue disease

Differential diagnosis

(typically systemic lupus erythematosus). Eosinophilia suggests

Blood cultures

Churg–Strauss syndrome or a drug reaction.

Viral serology

 

Liver function tests

Echocardiography

 

 

Abnormal results suggest viral infection (hepatitis A, B or C) or may be non-specific.

Immunology

ANCA are associated with the primary systemic necrotizing vasculitides. ANCA in association with proteinase 3 antibodies are highly specific (>90%) for Wegener’s granulomatosis. Perinuclear ANCA (pANCA) associated with myeloperoxidase antibodies occur in microscopicpolyangiitisandChurg–Strausssyndrome.Rheumatoid factors and antinuclear antibodies may indicate vasculitis associated with connective tissue disease. Complement levels are low in infection, lupus and cryoglobulinaemia.

Biopsy

Tissue biopsy is important to confirm the diagnosis before treatment with potentially toxic immunosuppressive drugs. The choice of tissue to biopsy is crucial.

Other investigations

Angiography can show aneurysms. Blood cultures, viral serology and echocardiography are important to exclude infection and other conditions that may present as systemic multi-system disease and mimic vasculitis (Boxes 23.3 and 23.4).

Источник: https://studfile.net/preview/16670064/